Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | S100A4 | P26447 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.40 |
| ▸ | PTPRC | P08575 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL946835 | 0.98 | TSHR (0.57) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL118464 | 0.84 | TSHR (0.71) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL1926046 | 0.84 | TSHR (0.71) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL29669769 | 0.81 | TSHR (0.68) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL7157905 | 0.81 | TSHR (0.68) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL27735242 | 0.81 | TSHR (0.68) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL28529002 | 0.81 | TSHR (0.68) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL7157907 | 0.81 | TSHR (0.68) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| Fluoride SCHEMBL29099623 | 0.81 | TSHR (0.68) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 | |
| Hydrogen Sulfide SCHEMBL28144547 | 0.81 | TSHR (0.68) | TSHRGPR35TDP1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4841030-A | Azo reactive dyestuffs | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-20 | — | — | US | claimed |
| JP-55045721-A | — | — | None | — | — | JP | disclosed |
| US-5066783-A | Antiviral peptides and means for treating herpes infections | COHEN ERIC A (CA) | 1991-11-19 | — | — | US | disclosed |
| US-RE32992-E | THERAPY FOR INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS | Fujisawa Pharaceutical Co., Ltd. (JP) | 1989-07-18 | — | — | US | disclosed |
| US-4801580-A | Peptide, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1989-01-31 | — | — | US | disclosed |
| US-4795740-A | Antiviral peptides and means for treating herpes infections | COHEN ERIC A (CA) | 1989-01-03 | — | — | US | disclosed |
| US-4749691-A | Peptide, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-06-07 | — | — | US | disclosed |
| US-4725582-A | IMMUNE RESPONSE ENHANCERS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1988-02-16 | — | — | US | disclosed |
| EP-0246630-A2 | Antiviral peptides and means for treating herpes infections | Cohen, Eric A. (CA) | 1987-11-25 | — | — | EP | disclosed |
| EP-0025842-B1 | PEPTIDES, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR INTERMEDIATES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-06-03 | — | — | EP | disclosed |
| US-4458078-A | SYNTHESIS OF OLIGOPEPTIDES | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1984-07-03 | — | — | US | disclosed |
| US-4354966-A | Peptides, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-10-19 | — | — | US | disclosed |
| US-4311640-A | ANTIBIOTIC | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-01-19 | — | — | US | disclosed |
| US-4304718-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-08 | — | — | US | disclosed |
| EP-0027260-A2 | Peptides, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-22 | — | — | EP | disclosed |
| EP-0025842-A2 | Peptides, process for their preparation, their pharmaceutical compositions and their intermediates | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-01 | — | — | EP | disclosed |
| US-4237305-A | INTERMEDIATES FOR PREPARING NEW ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-12-02 | — | — | US | disclosed |
| JP-S5545721-A | EXPANDABLE STYRENE-BASED POLYMER BEADS AND PREPARATION OF THE SAME | DENKI KAGAKU KOGYO KK | 1980-03-31 | — | — | JP | disclosed |
| US-4181800-A | ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-4164571-A | Medicament which antagonizes the action of gastrin and related polypeptides | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1979-08-14 | — | — | US | disclosed |